» Articles » PMID: 24062930

Comparison of the Performance of the CRUSADE, ACUITY-HORIZONS, and ACTION Bleeding Risk Scores in STEMI Undergoing Primary PCI: Insights from a Cohort of 1391 Patients

Abstract

Aims: To compare the performance of the CRUSADE, ACUITY-HORIZONS, and ACTION risk models in the ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI).

Methods: We studied all consecutive patients with STEMI who underwent PPCI at our institution between 2006 and 2010 (n=1391). The CRUSADE, ACUITY-HORIZONS, and ACTION risk scores were calculated based on the patients' clinical characteristics. The occurrence of in-hospital major bleeding (defined as the composite of intracranial or intraocular bleeding, access site haemorrhage requiring intervention, reduction in haemoglobin ≥4 g/dl without or ≥3g/dl with overt bleeding source, reoperation for bleeding, or blood transfusion) reached 9.8%. Calibration and discrimination of the three risk models were evaluated by the Hosmer-Lemeshow test and the C-statistic, respectively. We compared the predictive accuracy of the risk scores by the DeLong non-parametric test.

Results: Calibration of the three risk scores was adequate, given the non-significant results of Hosmer-Lemeshow test for the three risk models. Discrimination of CRUSADE, ACUITY-HORIZONS, and ACTION models was good (C-statistic 0.77, 0.70, and 0.78, respectively). The CRUSADE and ACTION risk scores had a greater predictive accuracy than the ACUITY-HORIZONS risk model (z=3.89, p-value=0.0001 and z=3.51, p-value=0.0004, respectively). There was no significant difference between the CRUSADE and ACTION models (z=0.63, p=0.531).

Conclusions: The CRUSADE, ACUITY-HORIZONS, and ACTION scores are useful tools for the risk stratification of bleeding in STEMI treated by PPCI. Our findings favour the CRUSADE and ACTION risk models over the ACUITY-HORIZONS risk score.

Citing Articles

Association of Dephosphorylated-Uncarboxylated Matrix Gla Protein and Risk of Major Bleeding in Patients Presenting with Acute Myocardial Infarction.

Bilalic A, Kurir T, Borovac J, Kumric M, Supe-Domic D, Vilovic M Life (Basel). 2021; 11(8).

PMID: 34440477 PMC: 8400588. DOI: 10.3390/life11080733.


Shock Index-C: An Updated and Simple Risk-Stratifying Tool in ST-Segment Elevation Myocardial Infarction.

Ran P, Wei X, Lin Y, Li G, Huang J, He X Front Cardiovasc Med. 2021; 8:657817.

PMID: 34212012 PMC: 8241092. DOI: 10.3389/fcvm.2021.657817.


A Systematic Review on Bleeding Risk Scores' Accuracy after Percutaneous Coronary Interventions in Acute and Elective Settings.

Brinza C, Burlacu A, Tinica G, Covic A, Macovei L Healthcare (Basel). 2021; 9(2).

PMID: 33540514 PMC: 7912805. DOI: 10.3390/healthcare9020148.


Risk Assessment Using Risk Scores in Patients with Acute Coronary Syndrome.

Chan Pin Yin D, Azzahhafi J, James S J Clin Med. 2020; 9(9).

PMID: 32967247 PMC: 7565031. DOI: 10.3390/jcm9093039.


Development and Validation of a Novel Risk Score for In-Hospital Major Bleeding in Acute Myocardial Infarction:-The SWEDEHEART Score.

Simonsson M, Winell H, Olsson H, Szummer K, Alfredsson J, Hall M J Am Heart Assoc. 2019; 8(5):e012157.

PMID: 30803289 PMC: 6474938. DOI: 10.1161/JAHA.119.012157.


References
1.
Montalescot G, Gallo R, White H, Cohen M, Steg P, Aylward P . Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention 1-year results from the STEEPLE (SafeTy and efficacy of enoxaparin in percutaneous coronary intervention patients, an international randomized evaluation) trial. JACC Cardiovasc Interv. 2009; 2(11):1083-91. DOI: 10.1016/j.jcin.2009.08.016. View

2.
Jepsen P, Johnsen S, Gillman M, Sorensen H . Interpretation of observational studies. Heart. 2004; 90(8):956-60. PMC: 1768356. DOI: 10.1136/hrt.2003.017269. View

3.
Manoukian S . Predictors and impact of bleeding complications in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction. Am J Cardiol. 2009; 104(5 Suppl):9C-15C. DOI: 10.1016/j.amjcard.2009.06.020. View

4.
Mehran R, Pocock S, Nikolsky E, Clayton T, Dangas G, Kirtane A . A risk score to predict bleeding in patients with acute coronary syndromes. J Am Coll Cardiol. 2010; 55(23):2556-66. DOI: 10.1016/j.jacc.2009.09.076. View

5.
Jolly S, Yusuf S, Cairns J, Niemela K, Xavier D, Widimsky P . Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet. 2011; 377(9775):1409-20. DOI: 10.1016/S0140-6736(11)60404-2. View